Instil Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
Instil confirms cash runway beyond 2026 ITIL-306 phase 1 study anticipated to receive CTA clearance…
News
Bio-Path Holdings Reports Full Year 2022 Financial Results
Conference Call to be Held Today at 8:30 A.M. ET HOUSTON, March 31, 2023 (GLOBE…
Bio-Path Holdings Reports Full Year 2022 Financial Results
Conference Call to be Held Today at 8:30 A.M. ET HOUSTON, March 31, 2023 (GLOBE…
BioCryst Appoints Dr. Nancy Hutson as Chair of the Board
RESEARCH TRIANGLE PARK, N.C., March 31, 2023 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX)…
BioCryst Appoints Dr. Nancy Hutson as Chair of the Board
RESEARCH TRIANGLE PARK, N.C., March 31, 2023 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX)…
Disc Medicine Reports Full Year 2022 Financial Results and Provides Business Update
Completed reverse merger with Gemini Therapeutics, debuting on Nasdaq as “IRON” and ending 2022 with…
Disc Medicine Reports Full Year 2022 Financial Results and Provides Business Update
Completed reverse merger with Gemini Therapeutics, debuting on Nasdaq as “IRON” and ending 2022 with…
Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility
DURHAM, N.C., March 31, 2023 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the…
Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility
DURHAM, N.C., March 31, 2023 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the…
Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer’s Disease to be Presented by Dr. Howard Weiner at the International Conference on Alzheimer’s and Parkinson’s Disease and Related Neurological Disorders Conference in Sweden
Data shows reduction of microglia activation and improvement in behavior in rodent model of Alzheimer’s…
Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer’s Disease to be Presented by Dr. Howard Weiner at the International Conference on Alzheimer’s and Parkinson’s Disease and Related Neurological Disorders Conference in Sweden
Data shows reduction of microglia activation and improvement in behavior in rodent model of Alzheimer’s…
Cabaletta Bio Receives FDA Clearance of IND Application for CABA-201 for Treatment of Systemic Lupus Erythematosus
– IND application cleared within 6 months of in-licensing CABA-201 binder – – CABA-201 data…
Cabaletta Bio Receives FDA Clearance of IND Application for CABA-201 for Treatment of Systemic Lupus Erythematosus
– IND application cleared within 6 months of in-licensing CABA-201 binder – – CABA-201 data…
Verizon Earns 5-Star Rating in 2023 CRN® Partner Program Guide
Verizon Business continues to be an industry leader for over 5,000 partners in the Verizon…
Verizon Earns 5-Star Rating in 2023 CRN® Partner Program Guide
Verizon Business continues to be an industry leader for over 5,000 partners in the Verizon…
Defense Technologies International Corp. Shareholder Update – DTII Market Potential
Del Mar, California–(Newsfile Corp. – March 31, 2023) – Defense Technologies International Corp. (OTC Pink:…
French Perfume Brand Bon Parfumeur Announces Launch of New Perfume Collection
Paris, France–(Newsfile Corp. – March 31, 2023) – Bon Parfumeur, the French perfume brand, has…
Defense Technologies International Corp. Shareholder Update – DTII Market Potential
Del Mar, California–(Newsfile Corp. – March 31, 2023) – Defense Technologies International Corp. (OTC Pink:…
XAPP Design Expands Custom Website Development & SEO Services in Charleston, WV
XAPP Design Inc. (866-477-9277), a company based in Charleston, WV, has expanded its range of…
XAPP Design Expands Custom Website Development & SEO Services in Charleston, WV
XAPP Design Inc. (866-477-9277), a company based in Charleston, WV, has expanded its range of…